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AbstrACt
Objective To assess the performance of currently 
available sepsis recognition tools in patients referred to 
a community-based acute ambulatory care unit.
Design Service evaluation of consecutive patients over a 
4-month period.
setting Community-based acute ambulatory care unit.
Data collection and outcome 
measures Observations, blood results and outcome 
data were analysed from patients with a suspected 
infection. Clinical features at first assessment were 
used to populate sepsis recognition tools including: 
systemic inflammatory response syndrome (SIRS) 
criteria, National Early Warning Score (NEWS), quick 
Sequential Organ Failure Assessment (qSOFA) and 
National Institute for Health and Care Excellence 
(NICE) criteria. Scores were assessed against the 
clinical need for escalated care (use of intravenous 
antibiotics, fluids, ongoing ambulatory care or hospital 
treatment) and poor clinical outcome (all-cause 
mortality and readmission at 30 days after index 
assessment).
results Of 533 patients (median age 81 years), 316 
had suspected infection with 120 patients requiring 
care escalated beyond simple community care. SIRS 
had the highest positive predictive value (50.9%, 95% 
CI 41.6% to 60.3%) and negative predictive value 
(68.9%, 95% CI 62.6% to 75.3%) for the need for 
escalated care. Both NEWS and SIRS were better at 
predicting the need for escalated care than qSOFA and 
NICE criteria in patients with suspected infection (all 
P<0.001). While new-onset confusion predicted the 
need for escalated care for infection in patients ≥85 
years old (n=114), 23.7% of patients ≥85 years had 
new-onset confusion without evidence for infection.
Conclusions Acute ambulatory care clinicians should 
use caution in applying the new NICE endorsed criteria 
for determining the need for intravenous therapy and 
hospital-based location of care. NICE criteria have 
poorer performance when compared against NEWS 
and SIRS and new-onset confusion was prevalent in 
patients aged ≥85 years without infection.
IntrODuCtIOn 
Sepsis, defined as ‘life-threatening organ 
dysfunction caused by dysregulated host 
response to infection’,1 has a high mortality2 
but early recognition allows for prompt 
and effective treatment.3 Therefore, tools 
for accurate recognition are needed at the 
earliest possible point after patients attend an 
initial healthcare assessment setting.
The Third International Consensus Defini-
tions for Sepsis and Septic Shock (SEPSIS-3) 
advocates the Sequential Organ Failure 
Assessment (SOFA)1 score to evaluate sepsis. 
However, SOFA is not practical to use in the 
community and the quick SOFA (qSOFA) 
score has been developed for use in rapid 
triage and in settings without access to blood 
tests.4 The National Institute for Health 
and Care Excellence (NICE) has recently 
introduced new guidance regarding sepsis, 
including a tool for the diagnosis and triage 
of patients with suspected sepsis in commu-
nity settings.2 The use of the qSOFA and the 
NICE high-risk and moderate-risk criteria 
(NICE-HR and NICE-MR, respectively) are a 
significant departure from the older systemic 
inflammatory response syndrome (SIRS) 
criteria.5 In addition to sepsis recognition, 
the National Early Warning Score (NEWS) 
strengths and limitations of this study
 ► Acute ambulatory care is applicable to an increas-
ingly prevalent healthcare delivery model.
 ► Consecutive patient evaluation to minimise selection 
bias.
 ► Not all elements of the sepsis recognition models 
were available for scoring.
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has been advocated by the Royal College of Physicians to 
track the clinical condition of patients presenting acutely 
for hospital and community assessment.6
New tools for sepsis recognition have not been evaluated 
in all healthcare environments that provide initial clin-
ical assessments. Lower sensitivity or specificity of either 
qSOFA or NICE criteria compared with existing tools for 
detecting sepsis at initial assessment, particularly in the 
community, could result in poorer care overall. Lower 
sensitivity results in missed cases of sepsis compared with 
current recognition tools and lower specificity results 
in the unnecessary escalation of care including rapid 
transfer from community settings to emergency depart-
ments, unnecessary use of broad-spectrum antibiotics and 
rapid fluid administration.
The performance of newer recognition scores, such as 
qSOFA and NICE criteria, may vary with clinical setting. 
Low specificity of NICE criteria has been suggested by the 
large number of acute medical unit admissions it detects 
as needing rapid assessment within 1 hour, in comparison 
with qSOFA and SIRS.7 8 Furthermore, among emergency 
department patients with low qSOFA scores, a signifi-
cant proportion require critical care interventions which 
would not have been anticipated using qSOFA9 and the 
now abandoned SIRS criteria have shown more accu-
rate prediction of death than qSOFA in some emergency 
department cohorts.10 Given that in intensive care unit 
patients, SOFA has a better performance than SIRS,11 12 it 
is likely that the clinical setting and nature of the patient 
cohorts in which these tools are applied have a strong 
influence on their accuracy to detect sepsis and stratify 
patients based on risk of poor outcomes.
The acute ambulatory care model, which is recom-
mended as a strategy in acute medicine to meet increasing 
demands for care within constrained resources,13 
represents a particular challenge for the recognition of 
sepsis. While ambulatory care is becoming increasingly 
prevalent,14 there are very few tools designed to support 
clinical decision making in the ambulatory care envi-
ronment. Patients who are deemed suitable for ambula-
tory care do not have very disordered physiology,15 even 
though there may be an emerging underlying significant 
disease process. Furthermore, identification of sepsis 
in older patients with frailty is complex as acute func-
tional decline has many other causes,16 yet mortality and 
morbidity related to sepsis is higher in the older popula-
tion.17 One of the critical decisions in ambulatory care 
management of suspected infection is selecting which 
patients can be safely discharged with oral therapy and 
follow-up from their general practitioner and which 
patients are at higher risk of clinical deterioration and 
require care that is enhanced, either through an ambula-
tory platform with daily parenteral antibiotics with senior 
clinical review or medical admission.
The ambulatory care clinician, faced with the diagnostic 
and management challenge of early sepsis recognition 
and the need to safely manage patients on an ambulatory 
pathway, can choose from four different sepsis recognition 
tools (SIRS, NEWS, NICE-HR and NICE MR and qSOFA). 
This study aims to evaluate the performance of these tools 
by examining their association with processes of care and 
clinical outcomes in patients with suspected infection in 
an acute ambulatory care setting. Given the uncertainty 
about application to older people in whom there is a wide 
differential diagnosis for acute frailty syndromes such as 
confusion, we undertook a subgroup analysis in patients 
85 years or older.
MethODs
The direct care team collected healthcare data as part of 
routinely provided healthcare from consecutive patients 
presenting to the Abingdon Hospital’s Emergency Multi-
disciplinary Unit (EMU) run by Oxford Health NHS 
Foundation Trust between 12/08/2015 and 08/12/2015. 
Patients were included if they were residents within 
Oxfordshire, allowing for appropriate follow-up details 
to be obtained and had a clinical phenotype suggesting 
possible infection, in keeping with the recommended 
application of sepsis screening tools.5 The use of routine 
healthcare data collected by the direct care team for the 
purposes of determining adherence to national guidance 
and application of clinical prediction tools to inform 
future service development was prospectively approved 
as a service evaluation by the Oxford University Hospi-
tals NHS Foundation Trust (providers of the medical care 
on EMU), with audit Datix reference number 3812, and 
permission to publish was granted by the Oxford Health 
NHS Foundation Trust R&D Department.
study setting
The EMU model of care provides assessment and treat-
ment for adults with acute illness where an ambulatory 
treatment path is considered likely by the initial contact 
healthcare provider. Facilities include point-of-care blood 
testing (electrolytes, renal function, blood gases, lactate, 
C reactive protein, troponin, International Normalised 
Ratio (INR)), plain X-ray and intravenous delivery of 
medications and fluids. Referrals are primarily from 
general practitioners and paramedic teams in the commu-
nity. Patients whose care needs cannot be met with an 
ambulatory pathway are admitted to either a community 
hospital or an associated acute hospital.
Process of care and clinical outcomes
Details regarding the patients’ presentation, investiga-
tions, treatment and outcome were prospectively docu-
mented at the time of assessment on the EMU. Patients’ 
initial assessment was undertaken using a structured clin-
ical clerking proforma including a brief cognitive test 
(the Abbreviated Mental Test Score and delirium screen) 
as described previously.18 Data for analyses were extracted 
from the clerking proforma supplemented by informa-
tion from ambulance sheets, general practitioner referral 
letters and communications with patients and relatives 
as listed in online supplementary table 1. Patients were 
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considered to have a possible infection if a clinical suspi-
cion of infection was recorded by the treating clinician or 
if the presenting complaint suggested an infective cause 
for their symptoms. Processes of care included use of 
intravenous antibiotics, intravenous fluids and pathway of 
care (ambulatory vs hospital) and readmission within 30 
days. Clinical outcome was 30-day all-cause mortality.
We tested the ability of sepsis scoring systems to select 
patients who require continued monitoring and treatment 
from the medical team, either via ambulatory or bed-based 
pathways. Patients were considered to have required esca-
lated care for an infection if all of the following condi-
tions were met: (1) the patient had a possible infection, 
(2) the patient received intravenous antibiotics and intra-
venous fluids, (3) the patient was either admitted to an 
inpatient facility or subsequently brought back to the 
EMU for ≥1 daily reviews, or enrolled in the ‘hospital @ 
home’ programme to receive ongoing intravenous anti-
biotics and daily review after initial EMU assessment. 
Furthermore, patients with suspected infection who did 
not meet conditions (2) and (3) were considered to have 
needed escalated care if they died within 7 days of review 
or required readmission for infection within 30 days. This 
strategy was used as it collectively identifies patients for 
whom initial discharge from ambulatory care with no or 
oral antibiotics may have been inappropriate.
sepsis scoring systems
We evaluated the accuracy of SIRS,18 qSOFA,6 NEWS,2 
NICE-HR and NICE-MR from NICE Guideline NG517 for 
detecting the need for escalated care to treat suspected 
bacterial infection. Each method was undertaken in 
accordance with guidance provided by issuing bodies. 
Features associated with these tools available in our 
data set and cut-off values for prediction of sepsis or poor 
outcome are detailed in online supplementary table 2. 
Within selected scoring systems (NICE-MR, NICE-HR), 
some variables are not systematically available at the 
first assessment in an acute setting (eg, urine output, 
usual blood pressure values for calculation of difference 
from observed value) and online supplementary table 2 
lists these variables together with any additional clinical 
features that were not systematically sought within the 
clerking proforma. The scores were calculated without 
use of these items which would reflect real-world prac-
tice after implementation. A cut-off score of >4 was used 
for NEWS in line with guidance from the Royal College 
of Physicians (London) which details this threshold for 
separating low-risk patients from those at increased risk.7 
For cases in which individual items required for a score 
were missing, the score for that individual was calculated 
without that item, in line with clinical practice. During the 
analysis, NICE-MR and NICE-HR were combined in some 
analyses to replicate the use of the moderate criteria in 
clinical practice. We did not separately analyse the Sepsis 
Trust Red/Amber flag system (https:// sepsistrust. org/ 
education/ clinical- tools/) as features of this system were 
incorporated into the new NICE guidelines.
statistical analysis
Continuous variables are expressed as either mean (SD) 
or median (IQR) and compared across suspected infec-
tion/no suspected infection and escalated care/no esca-
lated care groups using the independent Student’s t-test 
or Mann-Whitney U-test, respectively. Categorical and 
ordinal variables are reported as frequency (percentage) 
and compared between groups using the χ2 or Fisher’s 
exact test. The diagnostic accuracy of each predictive tool 
was assessed using positive predictive value (PPV), nega-
tive predictive value (NPV), sensitivity and specificity, 
with 95% CIs. Predictive tools were compared with one 
another using McNemar’s test, and we consider P values 
of less than 0.005 to be statistically significant in these 
comparisons (based on a conservative Bonferroni correc-
tion for 10 comparisons). The performance of sepsis tools 
was assessed in the whole data set and in a subgroup of 
the oldest patients (≥85 years) in predicting the need for 
escalated care, mortality and readmission within 30 days 
of index assessment. Analysis was performed using V.9 of 
the SAS system for Windows (Copyright © 2002–2010 by 
SAS Institute, Cary, North Carolina, USA).
PAtIent InvOlveMent
This study was a service evaluation. There was no direct 
patient involvement in its conduct.
results
A total of 533 patients were assessed during the observa-
tion time period. Ten patients were not local residents and 
did not have follow-up data and were excluded from the 
analysis (figure 1). Demographic data of the study popu-
lation are provided in table 1. Three hundred and sixteen 
patients were considered to have a potential infection 
with 120 patients requiring escalated treatment for infec-
tion. Features most significantly associated with need for 
escalated care were increased heart rate (89.6 (18.9) vs 
83.8 (17.8), P=0.006), increased temperature (37.0 (0.9) 
vs 36.6 (0.6), P<0.001) and increased white cell count 
(14.5 (17.4) vs 9.3 (3.7), P=0.003). In the whole cohort, 
there was no association between new-onset confusion 
and need for escalated care (22/120 (20.0%) vs. 27/196 
(14.0%), P=0.172). A full list of features associated with 
escalated care is displayed in table 1.
Of 186 patients ≥85 years old (45% of the cohort), 114 
patients had a suspected infection as the cause for their 
presentation. Among patients ≥85 years with suspected 
infection, those who met criteria for escalated care (n=35, 
30.7%) also demonstrated the positive findings for the 
whole cohort in terms of difference in physiological 
markers, but new confusion was significantly associated 
with escalated care in this subgroup (table 1).
The PPV, NPV, sensitivity and specificity of each assess-
ment tool against the need for escalated care, 30-day 
mortality, 30-day admission and a composite marker 
of 30-day mortality or admission for the cohort with 
 o
n
 12 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-020497 on 9 April 2018. Downloaded from 
4 Camm CF, et al. BMJ Open 2018;8:e020497. doi:10.1136/bmjopen-2017-020497
Open Access 
suspected infection are shown in table 2. SIRS had the 
highest PPV (50.9%, 95% CI 41.6% to 60.3%) and NPV 
(68.9%, 95% CI 62.6% to 75.3%). Using McNemar’s test, 
the combined high-risk and moderate-risk NICE criteria 
were shown to be significantly worse at predicting 
escalated care compared with SIRS (P<0.001), NEWS 
(P<0.001) and NICE-HR criteria alone (P=0.004) 
(table 3), a result driven by very low specificity of the 
combined high-risk and moderate-risk NICE criteria 
(21.4%, 95% CI 15.7 to 27.2). Furthermore, both SIRS 
and NEWS were shown to have better performance 
against qSOFA (both P<0.001). NEWS and SIRS had 
the highest specificity for detecting 30-day mortality 
(67.0, 95% CI 61.6 to 72.4 and 73.5, 95% CI 68.5 to 78.6, 
respectively).
Among patients ≥85 years old, the PPV and NPV of both 
SIRS and NEWS were higher than NICE or qSOFA scores 
for escalated care and for the combined 30-day clinical 
outcome (see online supplementary table 3). While 
NICE criteria had the highest sensitivity at detecting 
poor clinical outcomes (mortality or admission within 30 
days) (88.4%), this was at the cost of very low specificity 
(14.3%). Receiver operating characteristic curves for the 
ability of the different sepsis scoring systems to identify 
Figure 1 Patient flow from clinical presentation to outcomes. IV, intravenous.
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patients requiring escalated care are shown in online 
supplementary figure 1.
DIsCussIOn
Of the tools assessed, SIRS and NEWS were shown to have 
the highest PPV and NPV for escalated care in the data set 
overall and in the subgroup of patients ≥85 years. While 
NICE criteria and qSOFA had better performance in 
detecting requirement for escalated care in patients ≥85 
years, their poorer specificity contributed to a lower PPV. 
The presence of new confusion was associated with esca-
lated care among patients with suspected infection in the 
subgroup of patients aged ≥85 years.
Although SIRS was shown to be the most predictive of 
escalated care in patients with suspected infection in this 
study, the combined high-risk and moderate-risk NICE 
criteria would capture the most patients requiring esca-
lated care but at the cost of very low specificity, that is, 
a high false-positive rate. These results contrast with the 
previously suggested limitations in predictive ability for 
poor outcomes when compared against other potential 
sepsis recognition and stratification tools which have led 
to a move away from using SIRS.5 This may reflect appli-
cability in different patient cohorts as Kaukonen et al 
demonstrated that 12.1% of intensive care unit patients 
with severe sepsis did not meet ≥2 SIRS criteria.2 19 20 
However, they also showed that those with SIRS positive 
sepsis had significantly increased mortality compared with 
those not meeting these criteria. Churpek et al demon-
strated that 47% of an acute patient cohort met ≥2 SIRS 
criteria during admission and concluded that screening 
patients for sepsis based on these criteria would be 
unwise.19 However, this paper did not select patients in 
whom infection was suspected and instead applied it to all 
admissions, irrespective of presenting complaint. A recent 
analysis from the same group has also suggested that in 
those admitted to hospital and suspected of infection, 
discrimination for in-hospital mortality was highest using 
Table 2 Analysis of scoring systems versus outcome measures in patients presenting to the Emergency Multidisciplinary Unit 
with suspected infection (n=316)
Outcome measure 
test
PPV (%) NPV (%) Sensitivity (%) Specificity (%)
Escalated care 
  SIRS 50.9 (41.6 to 60.3) 68.9 (62.6 to 75.3) 46.7 (37.7 to 55.6) 72.4 (66.2 to 78.7)
  NICE HR 39.5 (30.5 to 48.4) 62.9 (56.2 to 69.5) 37.5 (28.8 to 46.2) 64.8 (58.1 to 71.5)
  NICE MR and HR 38.4 (32.4 to 44.4) 63.6 (52.0 to 75.2) 80.0 (72.8 to 87.2) 21.4 (15.7 to 27.2)
  qSOFA 37.2 (30.2 to 44.2) 60.9 (52.6 to 69.2) 56.7 (47.8 to 65.5) 41.3 (34.4 to 48.2)
  NEWS >4 48.9 (38.4 to 59.3) 66.2 (60.1 to 72.4) 35.8 (27.3 to 44.4) 77.0 (71.2 to 82.9)
30-Day mortality 
  SIRS 12.7 (6.5 to 19.0) 94.7 (91.6 to 97.7) 56.0 (36.5 to 75.5) 67.0 (61.6 to 72.4)
  NICE HR 12.3 (6.3 to 18.3) 94.6 (91.4 to 97.7) 56.0 (36.5 to 75.5) 65.6 (60.2 to 71.1)
  NICE MR and HR 9.6 (5.9 to 13.3) 98.5 (95.5 to 100.0) 96.0 (88.3 to 100.0) 22.3 (17.6 to 27.1)
  qSOFA 11.5 (6.9 to 16.1) 97.0 (94.1 to 99.9) 84.0 (69.6 to 98.4) 44.3 (38.6 to 50.0)
  NEWS >4 12.5 (5.6 to 19.4) 93.9 (90.7 to 97.0) 44.0 (24.5 to 63.5) 73.5 (68.5 to 78.6)
30-Day readmission 
  SIRS 82.7 (75.7 to 89.8) 34.0 (27.5 to 40.4) 40.1 (33.7 to 46.5) 78.7 (70.1 to 87.2)
  NICE HR 74.6 (66.6 to 82.6) 29.7 (23.4 to 36.0) 37.4 (31.1 to 43.7) 67.4 (57.7 to 77.2)
  NICE MR and HR 74.8 (69.4 to 80.2) 39.4 (27.6 to 51.2) 82.4 (77.4 to 87.3) 29.2 (19.8 to 38.7)
  qSOFA 74.9 (68.6 to 81.1) 32.3 (24.4 to 40.3) 60.4 (54.0 to 66.7) 48.3 (37.9 to 58.7)
  NEWS >4 78.4 (69.8 to 87.0) 30.7 (24.7 to 36.7) 30.4 (24.4 to 36.4) 78.7 (70.1 to 87.2)
30-Day composite 
  SIRS 83.6 (76.7 to 90.5) 33.5 (27.1 to 39.9) 40.2 (33.8 to 46.5) 79.3 (70.8 to 87.8)
  NICE HR 75.4 (67.5 to 83.3) 29.2 (22.9 to 35.5) 37.6 (31.3 to 43.8) 67.8 (58.0 to 77.6)
  NICE MR and HR 75.6 (70.3 to 80.9) 39.4 (27.6 to 51.2) 82.5 (77.6 to 87.5) 29.9 (20.3 to 39.5)
  qSOFA 75.4 (69.2 to 81.6) 31.6 (23.7 to 39.5) 60.3 (53.9 to 66.6) 48.3 (37.8 to 58.8)
  NEWS >4 79.5 (71.1 to 88.0) 30.3 (24.3 to 36.2) 30.6 (24.6 to 36.5) 79.3 (70.8 to 87.8)
PPV, NPV, sensitivity and specificity show percentage and 95 % CI. 
NEWS, National Early Warning Score; NICE, National Institute for Health and Care Excellence; NPV, negative predictive value; PPV, 
positive predictive value; qSOFA, quick Sequential Organ Failure Assessment; SIRS, systemic inflammatory response syndrome.
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NEWS.21 Our results add to this information by providing 
support for the use of NEWS in identifying patients in 
need of care escalation in a community setting.
The importance of identifying sepsis in the initial stages 
of clinical contact to allow for prompt and effective treat-
ment has been well documented.20 However, our results 
have shown that those systems endorsed by both NICE 
and Sepsis-3 have limitations related to high false-posi-
tive rates as compared with both SIRS and NEWS, which 
could lead to substantial overtreatment.
The introduction of new-onset confusion as a predictor 
of sepsis in NICE guidance risks increasing the use of 
inappropriate antibiotics in the older patient with frailty. 
Although our results show a significant association 
between the development of new confusion and the need 
for escalated care among patients ≥85 years with infection, 
there was a high prevalence of new-onset confusion in this 
age group without any evidence of underlying infection. 
While infection is a principle cause of delirium,3 there is 
limited high-quality evidence that altered mental state in 
older adults is predictive of sepsis itself22 and delirium has 
a wide range of potential causes in older people.5
Our data show that the new combined NICE-HR and 
NICE-MR criteria are likely to significantly increase the 
number of patients that are determined as potentially 
having sepsis at initial assessment in ambulatory care. 
As such, this is likely to increase the number of patients 
receiving intravenous antibiotics which may conflict with 
the national and global priorities of antibiotic steward-
ship.22 Furthermore, in the ambulatory care setting their 
introduction may increase conversion to formal hospital 
admission which our data suggest will not be justified 
based on the clinical outcomes we recorded.
limitations
Several limitations of this work are acknowledged. Data 
collection for this work was undertaken at a time when 
SIRS was the recommended assessment tool for poten-
tial sepsis. As such, incorporation bias may explain some 
degree of the correlation between this method of assess-
ment and the diagnosis and treatment of sepsis. However, 
SIRS was not calculated as part of the standard assessment 
proforma in this cohort and white cell count was not avail-
able at initial review as it is not part of the point-of-care 
testing portfolio. This limitation would not explain the 
correlation between SIRS and NEWS with mortality at 
30 days.
Not all elements of the new NICE criteria for high-risk 
and moderate-risk sepsis were available for this analysis. 
However, the limited specificity of both these methods 
in determining sepsis would only be worsened by the 
addition of further criteria to this analysis. Furthermore, 
we argue that several of those unavailable elements (eg, 
mottled skin, cyanosis and urine output) represent those 
that would either not be available in the acute ambulatory 
setting or are based on subjective assessment and there-
fore more likely to vary between clinicians.
COnClusIOns
This study demonstrates that new NICE-recommended 
sepsis tools do not outperform the existing tools in an 
ambulatory care setting in predicting the need for esca-
lated care for infection and clinical outcomes at 30 
days. Although NICE tools had higher sensitivity, this 
was at the expense of very low specificity. SIRS had the 
highest predictive values but the requirement of a white 
cell count implies that it can only be used widely if this 
is tested at the point of care. Further research should 
be undertaken to determine applicability of NICE sepsis 
guidance in different healthcare settings where acutely 
unwell patients are assessed before widespread adoption 
in the National Health Service.
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